Literature DB >> 11465449

Intramolecular iron(II)-catalyzed nitrogen transfer reactions of unsaturated alkoxycarbonyl azides: a facile and stereoselective route to 4,5-disubstituted oxazolidinones.

T Bach1, B Schlummer, K Harms.   

Abstract

Intramolecular FeII-catalyzed reactions of various unsaturated alkoxycarbonyl azides are described. The reactions occur in the presence of stoichiometric amounts of trimethyl silyl chloride employing ethanol as the solvent. The corresponding 2-alkenyloxycarbonyl azides 5, 9, 18, 20, 22, and 24 gave the products 7/8, 10/11, 19, 21, 23, and 25 of an olefin chloroamination in moderate to good yields (47-72%). The facial diastereoselectivity of the ring closing C-N-bond forming step is good both in cyclic (20, 24) and in acyclic substrates (5, 18, 22) (>90% ds). The subsequent chlorine atom transfer occurs selectively in cyclic systems (20, 24) and in systems (9b, 18) which exhibit a conformational bias in the postulated radical intermediate 14. The lifetime tau of this elusive intermediate was estimated from the loss of stereochemical information in conformationally unrestricted systems (9a, 22) and from the data obtained with a radical clock (31-->32). 2-Alkynyloxycarbonyl azides 34 and 36 also yield chloroamination products which are obtained exclusively as the (Z)-isomers 35 and 37 (81-99% yield). The products of the tert-butyl-substituted substrates 38 undergo an immediate rearrangement/solvolysis reaction in the reaction mixture and gave the 5-alkoxyoxazolidinones 39 (93-99% yield).

Entities:  

Year:  2001        PMID: 11465449     DOI: 10.1002/1521-3765(20010618)7:12<2581::aid-chem25810>3.0.co;2-o

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  9 in total

1.  Recent advances in transition metal-catalyzed N-atom transfer reactions of azides.

Authors:  Tom G Driver
Journal:  Org Biomol Chem       Date:  2010-07-08       Impact factor: 3.876

2.  Glycal Metallanitrenes for 2-Amino Sugar Synthesis: Amidoglycosylation of Gulal-, Allal-, Glucal-, and Galactal 3-Carbamates.

Authors:  Simran Buttar; Julia Caine; Evelyne Goné; Reneé Harris; Jennifer Gillman; Roxanne Atienza; Ritu Gupta; Kimberly M Sogi; Lauren Jain; Nadia C Abascal; Yetta Levine; Lindsay M Repka; Christian M Rojas
Journal:  J Org Chem       Date:  2018-07-06       Impact factor: 4.354

3.  Rh2(II)-catalyzed nitro-group migration reactions: selective synthesis of 3-nitroindoles from β-nitro styryl azides.

Authors:  Benjamin J Stokes; Sheng Liu; Tom G Driver
Journal:  J Am Chem Soc       Date:  2011-03-14       Impact factor: 15.419

4.  Rhodium-catalyzed synthesis of 2,3-disubstituted indoles from β,β-disubstituted stryryl azides.

Authors:  Ke Sun; Sheng Liu; Patryk M Bec; Tom G Driver
Journal:  Angew Chem Int Ed Engl       Date:  2011-01-14       Impact factor: 15.336

5.  Enzymatic C(sp3)-H Amination: P450-Catalyzed Conversion of Carbonazidates into Oxazolidinones.

Authors:  Ritesh Singh; Joshua N Kolev; Philip A Sutera; Rudi Fasan
Journal:  ACS Catal       Date:  2015-01-29       Impact factor: 13.084

6.  Synthesis of azasilacyclopentenes and silanols via Huisgen cycloaddition-initiated C-H bond insertion cascades.

Authors:  Jiun-Le Shih; Santa Jansone-Popova; Christopher Huynh; Jeremy A May
Journal:  Chem Sci       Date:  2017-09-04       Impact factor: 9.825

7.  Formal synthesis of (-)-agelastatin A: an iron(II)-mediated cyclization strategy.

Authors:  Daisuke Shigeoka; Takuma Kamon; Takehiko Yoshimitsu
Journal:  Beilstein J Org Chem       Date:  2013-05-03       Impact factor: 2.883

8.  (4S)-4-[(R)-Chloro-(4-nitro-phen-yl)meth-yl]-1,3-oxazolidin-2-one.

Authors:  V Gaumet; C Denis; M Madesclaire; V P Zaitsev
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-04-24

9.  Iron(II)-catalyzed asymmetric intramolecular olefin aminochlorination using chloride ion.

Authors:  Cheng-Liang Zhu; Jun-Shan Tian; Zhen-Yuan Gu; Guo-Wen Xing; Hao Xu
Journal:  Chem Sci       Date:  2015-03-13       Impact factor: 9.825

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.